These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6549907)

  • 21. Clinical trials referral resource. Clinical trials using edatrexate.
    Cheson BD; Sorenson JM; Phillips PH
    Oncology (Williston Park); 1993 Jul; 7(7):33-4. PubMed ID: 8347459
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical trials referral resource. Clinical trials of MGI-114.
    Murgo A; Cannon DJ; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Feb; 13(2):233, 237-8. PubMed ID: 10079472
    [No Abstract]   [Full Text] [Related]  

  • 23. [Development for and clinical trials of molecular targeting drugs].
    Takashima A; Fukuda H; Shibata T
    Gan To Kagaku Ryoho; 2010 May; 37(5):822-7. PubMed ID: 20524257
    [No Abstract]   [Full Text] [Related]  

  • 24. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trials referral resource. Clinical trials of dolastatin-10.
    Wright JJ; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Jan; 13(1):68-70, 75. PubMed ID: 10027199
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trials referral resource. Clinical trials of single-agent oxaliplatin.
    Ivy SP; Blatner G; Cheson BD
    Oncology (Williston Park); 1999 Jul; 13(7):966, 969-70. PubMed ID: 10442343
    [No Abstract]   [Full Text] [Related]  

  • 27. Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials?
    Bruner DW
    J Clin Oncol; 2007 Dec; 25(34):5345-7. PubMed ID: 18048812
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical trials referral resource. Clinical trials using bryostatin-1.
    Pluda JM; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 May; 10(5):740-2. PubMed ID: 8738829
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical trials referral resource. Clinical trials with arsenic trioxide.
    Murgo AJ; McBee WL; Cheson BD
    Oncology (Williston Park); 2000 Feb; 14(2):206, 211, 215-6 passim. PubMed ID: 10736809
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials referral resource. Trials of topotecan.
    Cheson BD; Phillips PH; Arbuck SG
    Oncology (Williston Park); 1995 Mar; 9(3):220, 224-6, 228. PubMed ID: 7669515
    [No Abstract]   [Full Text] [Related]  

  • 31. Pilot studies and new agent programs of the Eastern Cooperative Oncology Group.
    Bennett JM; Zelen M
    Cancer Treat Rep; 1980; 64(2-3):525-32. PubMed ID: 7407794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical trials referral resource. Current clinical trials of bortezomib.
    Wright JJ; Zerivitz K; Schoenfeldt M
    Oncology (Williston Park); 2003 May; 17(5):677-80, 683-6, 691-2. PubMed ID: 12800794
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug trials in pediatric oncology: a multi-facetted problem.
    Boos J
    Int J Clin Pharmacol Ther; 1998 Nov; 36(11):613-20. PubMed ID: 9849753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical setbacks for toll-like receptor 9 agonists in cancer.
    Schmidt C
    Nat Biotechnol; 2007 Aug; 25(8):825-6. PubMed ID: 17687345
    [No Abstract]   [Full Text] [Related]  

  • 35. Retrospective analyses of cancer trials or existing clinical databases: potential for highly clinically relevant hypothesis generation.
    Markman M
    Oncology; 2012; 83(6):329-30. PubMed ID: 23007076
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor.
    Dancey JE; Schoenfeldt M
    Oncology (Williston Park); 2003 Jun; 17(6):819, 826-30, 833-4 passim. PubMed ID: 12846126
    [No Abstract]   [Full Text] [Related]  

  • 37. [Methods for clinical study of antineoplastic drugs].
    Lichinitser MR
    Vopr Onkol; 1986; 32(8):93-8. PubMed ID: 3765515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trials referral resource.
    Wright JJ; Zerivitz K; Gravell A
    Oncology (Williston Park); 2005 May; 19(6):722, 725-6, 728 passim. PubMed ID: 15971449
    [No Abstract]   [Full Text] [Related]  

  • 39. Compilation of 1982 Clinical Trials Summaries published in Cancer Treatment Reports.
    Cancer Treat Rep; 1982 Dec; 66(12):2101-3. PubMed ID: 6754078
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical development plan: beta-carotene and other carotenoids.
    Kelloff GJ; Crowell JA; Boone CW; Steele VE; Lubet RA; Greenwald P; Alberts DS; Covey JM; Doody LA; Knapp GG
    J Cell Biochem Suppl; 1994; 20():110-140. PubMed ID: 7616738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.